ST6GAL1 and liver cancer: Therefore, a better understanding of ST6Gal-I regulation and role in the treatment and diagnosis of hepatocarcinoma may lead to new antitumor strategies that will sensitize unresponsive liver cancers to docetaxel-based chemotherapy.